Market Currents
Cepheid (CPHD +1%) continues its upward trajectory today, having gained over 17% since last...
-
Monday, June 18, 2012, 2:32 PM ETCepheid (CPHD +1%) continues its upward trajectory today, having gained over 17% since last Thursday. Credit Suisse says it remains a top SMID cap pick given its best-in-class diagnostic testing platform and strong secular growth trends. Shares are Outperform rated with a $45 price target.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
